Fenghua Zeng

1.4k total citations
24 papers, 1.1k citations indexed

About

Fenghua Zeng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fenghua Zeng has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Fenghua Zeng's work include Cancer-related gene regulation (4 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Fenghua Zeng is often cited by papers focused on Cancer-related gene regulation (4 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Fenghua Zeng collaborates with scholars based in United States, China and Australia. Fenghua Zeng's co-authors include Raymond C. Harris, Amar B. Singh, Ming‐Zhi Zhang, Jianchun Chen, Steven J. Forrester, Satoru Eguchi, Dennis E. Hallahan, Carolyn Cao, Yi Ming Mu and Eric T. Shinohara and has published in prestigious journals such as Physiological Reviews, Nature Immunology and Cancer Research.

In The Last Decade

Fenghua Zeng

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fenghua Zeng United States 14 571 244 140 137 107 24 1.1k
Yanping Gong China 21 517 0.9× 219 0.9× 86 0.6× 201 1.5× 82 0.8× 54 1.1k
Philip M. Hemken United States 10 745 1.3× 188 0.8× 131 0.9× 71 0.5× 87 0.8× 15 1.0k
Song He China 19 615 1.1× 321 1.3× 122 0.9× 208 1.5× 75 0.7× 49 1.0k
Shujun Lin China 16 822 1.4× 354 1.5× 206 1.5× 179 1.3× 65 0.6× 49 1.4k
Xingbo Xu Germany 20 810 1.4× 126 0.5× 203 1.4× 200 1.5× 168 1.6× 46 1.4k
Rajeev Mahimkar United States 15 463 0.8× 323 1.3× 93 0.7× 372 2.7× 97 0.9× 18 1.1k
Anna Taranta Italy 21 808 1.4× 419 1.7× 96 0.7× 93 0.7× 39 0.4× 50 1.6k
Francis X. Farrell United States 25 779 1.4× 302 1.2× 220 1.6× 127 0.9× 191 1.8× 39 1.9k
Todd Seeley United States 12 685 1.2× 207 0.8× 202 1.4× 413 3.0× 42 0.4× 16 1.3k
Daisuke Ito Japan 14 573 1.0× 291 1.2× 107 0.8× 86 0.6× 32 0.3× 48 1.2k

Countries citing papers authored by Fenghua Zeng

Since Specialization
Citations

This map shows the geographic impact of Fenghua Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenghua Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenghua Zeng more than expected).

Fields of papers citing papers by Fenghua Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenghua Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenghua Zeng. The network helps show where Fenghua Zeng may publish in the future.

Co-authorship network of co-authors of Fenghua Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Fenghua Zeng. A scholar is included among the top collaborators of Fenghua Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenghua Zeng. Fenghua Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spann, Nathanael J., Wenxi Tang, Fenghua Zeng, et al.. (2025). Genetic variation in the activity of a TREM2–p53 signaling axis determines oxygen-induced lung injury. Nature Immunology. 26(8). 1287–1298.
2.
Zeng, Fenghua, et al.. (2024). Management of PICC rupture in a multidisciplinary collaborative model: A case report. The Journal of Vascular Access. 26(3). 1051–1054.
3.
Qin, Feng, et al.. (2022). MiR-539-3p inhibited chondrogenic differentiation in human adipose stem cells by targeting Sox9. Journal of Orthopaedic Surgery and Research. 17(1). 168–168. 8 indexed citations
4.
Voziyan, Paul, et al.. (2018). Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney. Kidney International. 94(2). 292–302. 9 indexed citations
5.
Zhu, Lin, Christopher H. Emfinger, Bryan A. Parks, et al.. (2018). CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet. Diabetes. 67(12). 2494–2506. 30 indexed citations
6.
Zeng, Fenghua, et al.. (2018). Prognostic significance of albumin-bilirubin grade in patients with hepatocellular carcinoma after R0 resection. Zhonghua gan-dan waike zazhi. 24(11). 747–750. 1 indexed citations
7.
Zeng, Fenghua, et al.. (2018). ErbB4 deletion predisposes to development of metabolic syndrome in mice. American Journal of Physiology-Endocrinology and Metabolism. 315(4). E583–E593. 43 indexed citations
8.
Zeng, Fenghua, et al.. (2017). ErbB4 deletion accelerates renal fibrosis following renal injury. American Journal of Physiology-Renal Physiology. 314(5). F773–F787. 25 indexed citations
9.
Yang, Haojie, Jinghang Jiang, Yuting Yang, et al.. (2016). Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival. World Journal of Gastroenterology. 22(39). 8798–8798. 13 indexed citations
10.
Zeng, Fenghua, et al.. (2016). Specific endothelial heparin-binding EGF-like growth factor deletion ameliorates renal injury induced by chronic angiotensin II infusion. American Journal of Physiology-Renal Physiology. 311(4). F695–F707. 24 indexed citations
11.
Zeng, Fenghua & Raymond C. Harris. (2014). Epidermal growth factor, from gene organization to bedside. Seminars in Cell and Developmental Biology. 28. 2–11. 151 indexed citations
12.
Zeng, Fenghua, et al.. (2014). Deletion of ErbB4 accelerates polycystic kidney disease progression in cpk mice. Kidney International. 86(3). 538–547. 18 indexed citations
13.
Miyazawa, Tomoki, Fenghua Zeng, Suwan Wang, et al.. (2013). Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression. Kidney International. 84(6). 1176–1188. 23 indexed citations
14.
Zeng, Fenghua & Raymond C. Harris. (2010). The ErbB Receptors and Their Ligands in PKD, an Overview. Current Signal Transduction Therapy. 5(2). 170–180. 1 indexed citations
15.
Zeng, Fenghua, Jie Xu, & Raymond C. Harris. (2009). Nedd4 mediates ErbB4 JM‐a/CYT–1 ICD ubiquitination and degradation in MDCK II cells. The FASEB Journal. 23(6). 1935–1945. 37 indexed citations
16.
Ma, Junfeng, Fenghua Zeng, Wan‐Ting Ho, et al.. (2008). Characterization and functional studies of a FYVE domain‐containing phosphatase in C. elegans. Journal of Cellular Biochemistry. 104(5). 1843–1852. 5 indexed citations
17.
Zeng, Fenghua, Amar B. Singh, & Raymond C. Harris. (2008). The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology. Experimental Cell Research. 315(4). 602–610. 121 indexed citations
18.
Zeng, Fenghua, Ming-Zhi Zhang, Amar Singh, Roy Zent, & Raymond C. Harris. (2007). ErbB4 Isoforms Selectively Regulate Growth Factor–induced Madin-Darby Canine Kidney Cell Tubulogenesis. Molecular Biology of the Cell. 18(11). 4446–4456. 37 indexed citations
19.
Shinohara, Eric T., Carolyn Cao, K.J. Niermann, et al.. (2005). Enhanced radiation damage of tumor vasculature by mTOR inhibitors. Oncogene. 24(35). 5414–5422. 153 indexed citations
20.
Xu, Fengping, et al.. (2002). Tyrosine Phosphatases SHP-1 and SHP-2 Are Associated with Distinct Tyrosine-Phosphorylated Proteins. Experimental Cell Research. 272(1). 75–83. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanping Gong Breakdown of academic impact, for papers by Philip M. Hemken Breakdown of academic impact, for papers by Song He Breakdown of academic impact, for papers by Shujun Lin Breakdown of academic impact, for papers by Xingbo Xu Breakdown of academic impact, for papers by Rajeev Mahimkar Breakdown of academic impact, for papers by Anna Taranta Breakdown of academic impact, for papers by Francis X. Farrell Breakdown of academic impact, for papers by Todd Seeley Breakdown of academic impact, for papers by Daisuke Ito
Rankless by CCL
2026